Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site

Valuation: Bio-Techne Corporation

Capitalization 11.92B 11.32B 10.53B 9.38B 16.78B 1,010B 18.53B 130B 48.44B 414B 44.78B 43.8B 1,791B P/E ratio 2025 *
62.5x
P/E ratio 2026 * 48x
Enterprise value 11.83B 11.24B 10.45B 9.31B 16.65B 1,003B 18.39B 129B 48.07B 411B 44.44B 43.47B 1,777B EV / Sales 2025 *
9.67x
EV / Sales 2026 * 8.63x
Free-Float
98.96%
Yield 2025 *
0.43%
Yield 2026 * 0.44%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.12%
1 week+0.68%
Current month+0.70%
1 month-0.01%
3 months+6.71%
6 months-1.31%
Current year-1.65%
More quotes
1 week
73.68
Extreme 73.68
76.81
1 month
65.61
Extreme 65.61
80.80
Current year
61.16
Extreme 61.16
85.57
1 year
61.16
Extreme 61.16
85.57
3 years
51.79
Extreme 51.79
130.74
5 years
38.79
Extreme 38.7925
135.96
10 years
19.99
Extreme 19.9875
135.96
More quotes
Director TitleAgeSince
Chief Executive Officer 57 31/01/2024
Director of Finance/CFO 53 31/03/2014
Investor Relations Contact - 30/09/2019
Manager TitleAgeSince
Chairman 68 01/11/2012
Director/Board Member 54 18/05/2009
Director/Board Member 74 25/05/2010
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+1.12%+0.68%+16.22%-35.17%11.92B
+0.65%-0.49%+57.83%-26.45%42.79B
+1.29%+0.86%-6.06%-22.78%36.41B
-2.09%+4.21%+12.20%-7.78%27.1B
+0.71%+0.78%-19.55%-19.34%17.58B
+1.52%-0.99%+56.04%+98.39%16.46B
-2.23%-4.06%-47.88%-84.31%16.39B
+2.08%+2.17%+23.89%+68.95%10.52B
+0.03%-0.12%-0.63%-43.27%10.19B
+1.11%+0.05%+2.28%-20.46%9.62B
Average +0.47%-0.22%+9.44%-9.22% 19.9B
Weighted average by Cap. +0.32%-0.51%+14.27%-13.09%
See all sector performances

Financials

2025 *2026 *
Net sales 1.22B 1.16B 1.08B 962M 1.72B 104B 1.9B 13.37B 4.97B 42.51B 4.59B 4.49B 184B 1.34B 1.27B 1.18B 1.05B 1.88B 113B 2.08B 14.62B 5.43B 46.48B 5.02B 4.91B 201B
Net income 198M 188M 175M 156M 278M 16.76B 307M 2.16B 804M 6.87B 743M 727M 29.71B 261M 248M 231M 205M 368M 22.13B 406M 2.86B 1.06B 9.08B 981M 960M 39.23B
Net Debt -90.53M -85.97M -79.96M -71.2M -127M -7.67B -141M -990M -368M -3.15B -340M -333M -13.59B -379M -360M -335M -298M -534M -32.15B -590M -4.15B -1.54B -13.19B -1.43B -1.39B -56.98B
More financial data * Estimated data
Logo Bio-Techne Corporation
Bio-Techne Corporation specializes in the manufacture and marketing of products used in life science research. The group offers reagents and diagnostic tools for researchers, doctors, laboratories, pharmaceutical and biotechnology companies, etc. Net sales break down by family of products as follows: - biological and chemical reagents and analysis tools 71.5%): proteins, antibodies, molecules, culture serums, tools for cell work, tools for the study of proteins, immunoassay tools, etc.; - diagnostic and genomics products (28.1%): reagents and products used in blood analysis, nucleic acid analysis, tissue biopsy, gene analysis, cancer and genetic carrier screening, etc. ; - other (0.4%). Net sales are distributed geographically as follows: the United States (56.7%), the United Kingdom (4.3%), Europe-Middle East-Africa (20.8%), China (8.6%), Asia-Pacific (6.5%) and others (3.1%).
Employees
3,100
More about the company
Date Price Change Volume
04/12/24 75.89 $ +1.12% 571,306
03/12/24 75.05 $ -1.28% 595,596
02/12/24 76.02 $ +0.88% 922,632
29/11/24 75.36 $ -0.03% 464,410
27/11/24 75.38 $ +0.68% 557,025

Delayed Quote Nasdaq, December 04, 2024 at 09:00 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B+
surperformance-ratings-light-chart BIO-TECHNE-CORPORATIONMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
75.05USD
Average target price
85.25USD
Spread / Average Target
+13.59%
Consensus

Quarterly revenue - Rate of surprise

Exceptional Extension | BLACK FRIDAY -40% : Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW